+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Therapeutic Drug Monitoring Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update

  • PDF Icon

    Report

  • 242 Pages
  • November 2024
  • Region: Global
  • GlobalData
  • ID: 5656159
The Medical Devices sector report, “Therapeutic Drug Monitoring Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update" provides comprehensive information about the Therapeutic Drug Monitoring pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Therapeutic drug monitoring tests include reagents and test kits intended to measure different types of therapeutic drugs from samples ranging from serum/blood, urine, hair and sweat.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Therapeutic Drug Monitoring under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Therapeutic Drug Monitoring and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to Buy

The report enables you to:

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Therapeutic Drug Monitoring under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Therapeutic Drug Monitoring Overview
3 Products under Development
3.1 Therapeutic Drug Monitoring - Pipeline Products by Stage of Development
3.2 Therapeutic Drug Monitoring - Pipeline Products by Segment
3.3 Therapeutic Drug Monitoring - Pipeline Products by Territory
3.4 Therapeutic Drug Monitoring - Pipeline Products by Regulatory Path
3.5 Therapeutic Drug Monitoring - Pipeline Products by Estimated Approval Date
3.6 Therapeutic Drug Monitoring - Ongoing Clinical Trials
4 Therapeutic Drug Monitoring - Pipeline Products under Development by Companies
4.1 Therapeutic Drug Monitoring Companies - Pipeline Products by Stage of Development
4.2 Therapeutic Drug Monitoring - Pipeline Products by Stage of Development
5 Therapeutic Drug Monitoring Companies and Product Overview6 Therapeutic Drug Monitoring- Recent Developments
7 Appendix
7.1 Methodology
7.2 About the Analyst
7.3 Contact the Publisher
7.4 Disclaimer
List of Tables
  • Therapeutic Drug Monitoring - Pipeline Products by Stage of Development
  • Therapeutic Drug Monitoring - Pipeline Products by Segment
  • Therapeutic Drug Monitoring - Pipeline Products by Territory
  • Therapeutic Drug Monitoring - Pipeline Products by Regulatory Path
  • Therapeutic Drug Monitoring - Pipeline Products by Estimated Approval Date
  • Therapeutic Drug Monitoring - Ongoing Clinical Trials
  • Therapeutic Drug Monitoring Companies - Pipeline Products by Stage of Development
  • Therapeutic Drug Monitoring - Pipeline Products by Stage of Development
  • Therapeutic Drug Monitoring Test - Tuberculosis - Product Status
  • Therapeutic Drug Monitoring Test - Tuberculosis - Product Description
  • Glossary
List of Figures
  • Therapeutic Drug Monitoring - Pipeline Products by Stage of Development
  • Therapeutic Drug Monitoring - Pipeline Products by Segment
  • Therapeutic Drug Monitoring - Pipeline Products by Territory
  • Therapeutic Drug Monitoring - Pipeline Products by Regulatory Path
  • Therapeutic Drug Monitoring - Pipeline Products by Estimated Approval Date
  • Therapeutic Drug Monitoring - Ongoing Clinical Trials

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • 20/20 GeneSystems Inc
  • Abbott Diagnostics
  • Adaptive Biotechnologies Corp
  • Affinergy LLC
  • Age Labs AS
  • Animated Dynamics Inc
  • Applied Research using OMIC Sciences SL
  • ARK Diagnostics Inc
  • Avacta Group Plc
  • BG Medicine Inc
  • BIOHOPE Scientific SL
  • Boston University
  • CCC Diagnostics LLC
  • Centre Hospitalier Universitaire de Nice
  • Chronix Biomedical Inc
  • Cognizance Biomarkers LLC
  • Columbia University
  • ContraVac Inc (Inactive)
  • Denovo Biolabs Pvt Ltd
  • DNAPrint Genomics Inc (Inactive)
  • Dublin City University
  • Ecole Polytechnique Federale de Lausanne
  • ELITechGroup Inc
  • Eurobio Scientific SA
  • Gene Express, Inc. (Inactive)
  • GenMark Diagnostics Inc
  • GlucoSentient Inc
  • HORIBA ABX SAS
  • Inflammatix Inc
  • Instrumentation Laboratory Co (Inactive)
  • Johns Hopkins University
  • Magnasense AB
  • McMaster University
  • Medical Research Council
  • Metabolon Inc
  • Newcastle University
  • Nipro Europe N.V.
  • Nuclea Biotechnologies Inc. (Inactive)
  • PanGenomic Health Inc
  • Pax Neuroscience Inc
  • Pelago Bioscience AB
  • Pennsylvania State University
  • Plateletdiagnostics LLC
  • Prediction Sciences LLC (Inactive)
  • Prescient Medical Inc
  • Progenika Biopharma SA
  • Prometheus Laboratories Inc
  • Proteomika (Inactive)
  • Purdue University
  • Queen Mary University of London
  • Roche Diagnostics Corp
  • Roche Diagnostics International Ltd
  • Rockland Immunochemicals Inc
  • SAGA Diagnostics AB
  • Saladax Biomedical Inc
  • Sanofi
  • Siemens Healthcare Diagnostics Inc
  • Sirius Genomics Inc
  • Spanish National Research Council
  • SQI Diagnostics Inc
  • T2 Biosystems Inc
  • Thermo Fisher Scientific Inc
  • TrivarX Ltd
  • Universidade Feevale
  • University of Colorado
  • University of Colorado Denver
  • University of North Dakota
  • University of Queensland
  • University of Sao Paulo
  • University of Utah
  • University of Washington
  • Vesynta Ltd
  • Vyant Bio Inc (Inactive)
  • Zymeron Corp